Literature DB >> 17475313

Metastatic carcinoid tumor to the ovary: a clinicopathologic analysis of seventeen cases.

Jonathan Strosberg1, Aejaz Nasir, Janiel Cragun, Nancy Gardner, Larry Kvols.   

Abstract

OBJECTIVES: To evaluate the clinical behavior and histologic characteristics of metastatic carcinoid tumors to the ovary.
METHODS: Retrospective chart review and histologic specimen analysis of all patients with pathologically confirmed metastatic carcinoid tumor to the ovaries seen at the H. Lee Moffitt Cancer Center.
RESULTS: Seventeen patients with metastatic carcinoid tumors to the ovary were identified. The distal ileum was the site of origin among all patients with identifiable primary tumor. Fifteen patients (88%) had bilateral ovarian metastases. Other metastatic sites (in order of frequency) included liver, peritoneum breast and bone. Fifteen patients (88%) had elevated urinary 5-hydroxyindoleacetic acid (5-HIAA), indicating active serotonin secretion, and sixteen patients (94%) had radiotracer uptake on indium-111-pentetreotide scans. Five-year survival rate was 94%.
CONCLUSIONS: Metastatic carcinoid tumors to the ovary typically originate from distal ileal tumors and are nearly always bilateral. Synchronous metastases involve liver and peritoneal surfaces. Favorable survival rates may be associated with octretide treatment and cytoreductive surgery.

Entities:  

Mesh:

Year:  2007        PMID: 17475313     DOI: 10.1016/j.ygyno.2007.02.034

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

Review 1.  Debulking Surgery for Moderately Differentiated Neuroendocrine Gastric Carcinoma - A Case Report and Literature Review.

Authors:  Nicolae Bacalbasa; Iuliana Halmaciu; Ciprian Bolca; Adrian Neacsu; Dragos Cretoiu; Cristian Balalau; Camelia Diaconu; Laura Iliescu; Alexandru Filipescu; Cora Pop; Irina Balescu
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  Epidemiology of small bowel carcinoids in a defined population.

Authors:  Kalle Landerholm; Sture Falkmer; Johannes Järhult
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

3.  Metastases from neuroendocrine tumors to the breast are more common than previously thought. A diagnostic pitfall?

Authors:  Joakim Crona; Dan Granberg; Olov Norlén; Fredrik Wärnberg; Peter Stålberg; Per Hellman; Peyman Björklund
Journal:  World J Surg       Date:  2013-07       Impact factor: 3.352

4.  ACTH-secreting pancreatic neuroendocrine carcinoma with ovarian and pelvic metastases causing Cushing's syndrome: a case report.

Authors:  Wen-Qing Yao; Xia Wu; Gan-Di Li; Wei-Lu Wu; Wei-Ya Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

5.  Neuroendocrine tumours of the female genital tract: a case-based imaging review with pathological correlation.

Authors:  João Lopes Dias; Teresa Margarida Cunha; Filipe Veloso Gomes; Catarina Callé; Ana Félix
Journal:  Insights Imaging       Date:  2015-01-16

6.  Well-Differentiated Grade 2, Type 3 Gastrointestinal Neuroendocrine Tumour with Bilateral Metastatic Ovarian Involvement: Report of an Unusual Case.

Authors:  Ray Manneh; Daniel Castellano; Oscar Caso; Carmelo Loinaz; Jesús Jiménez; Juana Estenoz; Maria Calatayud; Juan M Sepúlveda; Rocio García-Carbonero
Journal:  Case Rep Oncol       Date:  2016-04-27

7.  Ectopic Cushing's Syndrome secondary to Recurrent Thymic Neuroendocrine Carcinoma with Bilateral Ovarian Metastases: A Case Report.

Authors:  Eunice Yi Chwen Lau; Zanariah Hussein
Journal:  J ASEAN Fed Endocr Soc       Date:  2021-05-04

8.  Metastatic VIPoma presenting as an ovarian mass.

Authors:  Jaron Mark; Stephen Bush; Evan Glazer; Jonathan Strosberg; Ozlen Saglam; Sachin M Apte
Journal:  Int J Surg Case Rep       Date:  2015-11-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.